← Eichor
Condition: Treatment Naive Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Treatment Naive

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
Phase 1 · 7 location(s) · Akamis Bio · NCT06459869Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis
Phase N/A · 12 location(s) · AstraZeneca · NCT06909253A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Phase 2 · 123 location(s) · ViiV Healthcare · NCT07202546Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07126678Odronextamab in Low Tumor Volume Advanced FL
Phase 2 · 1 location(s) · Gottfried von Keudell, MD PhD · NCT07128641Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease
Phase 2 · 1 location(s) · Ruijin Hospital · NCT07272499PRE-I-SPY Phase I/Ib Oncology Platform Program
Phase 1 · 7 location(s) · QuantumLeap Healthcare Collaborative · NCT05868226Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma
NA · 1 location(s) · Peking University Third Hospital · NCT07257510A Phase Ⅱa Clinical Study of CL-197 Capsules
Phase 2 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07308782Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Mul
Phase N/A · 1 location(s) · Qianfoshan Hospital · NCT06753981KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · 46 location(s) · Merck Sharp & Dohme LLC · NCT04165070Orelabrutinib and Rituximab With Optional Autologous Hematopoietic Stem Cell Transplantation in MCL Treatment
Phase 2 · 1 location(s) · Ruijin Hospital · NCT07199296Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal
Phase 3 · 1 location(s) · Yeungnam University College of Medicine · NCT07461441A Study to Evaluate the Efficacy and Safety of Zanubrutinib in Chinese Adults With Treatment-Naive Waldenström Macroglob
Phase 4 · 8 location(s) · BeiGene · NCT07169331Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Pa
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00039689Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals
Phase 1/Phase 2 · 1 location(s) · Shanxi Kangbao Biological Product Co., Ltd. · NCT07433387Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents
NA · 1 location(s) · University of Texas at Austin · NCT06523439Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treat
Phase 2 · 2 location(s) · Affiliated Hospital of Nantong University · NCT06530511SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · University of Washington · NCT05570825SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
Phase 3 · 1 location(s) · West China Hospital · NCT06627712Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive P
Phase 3 · 1 location(s) · Yeungnam University College of Medicine · NCT07389980VA Dual Sequential Therapy
Phase 4 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT06929962A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagno
NA · 6 location(s) · All India Institute of Medical Sciences · NCT06895252A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sint
Phase 2 · 4 location(s) · Tongji Hospital · NCT07350850Tumor Immune Microenvironment Involvement in Colorectal Cancer Chemoresistance Mechanisms
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT05038358The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk
Phase 3 · 1 location(s) · Ruijin Hospital · NCT05018520Study of Safety and Efficacy of MY008211A in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complem
Phase 3 · 2 location(s) · Wuhan Createrna Science and Technology Co., Ltd · NCT06932744Care Disengagement Prevention in PLWH in Indonesia
NA · 1 location(s) · University of California, Los Angeles · NCT07706634A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Par
Phase 3 · 224 location(s) · Janssen Research & Development, LLC · NCT06807424A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastas
Phase 2 · 1 location(s) · Latin American Cooperative Oncology Group · NCT06822543
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.